Vanda Pharmaceuticals (VNDA) Payables (2010 - 2026)
Vanda Pharmaceuticals' Payables came in at $69.99 million for Q2 2026, up 22.5% from $57.12 million a year earlier and up 15.5% from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Vanda Pharmaceuticals' Payables was $68.3 million, up 74.7% from FY2024.
- Payables carries a five-year compound annual growth rate of 16.7% (FY2020 to FY2025).
- Going back by year, Payables was $39.09 million in FY2024 (+1.6%), $38.46 million in FY2023 (-15.6%), $45.55 million in FY2022 (+32.3%) and $34.44 million in FY2021 (+9.3%).
- The Q2 2026 figure represents the highest quarterly Payables in data going back to Q4 2010.
- Year-over-year, Payables has increased for ten consecutive quarters, with growth averaging 29.8% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in Q1 2022 (growth of 96.9%), and the weakest in Q2 2023 (a decline of 36.4%).
- Business Quant data shows VNDA's Payables at $60.62 million (Q1 2026), $68.3 million (Q4 2025) and $47.62 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Vanda Pharmaceuticals | 312.55 Mn | -617.39 Mn | 46.97 Mn | 69.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.99 Mn |
| Mar 31, 2026 | 60.62 Mn |
| Dec 31, 2025 | 68.30 Mn |
| Sep 30, 2025 | 47.62 Mn |
| Jun 30, 2025 | 57.12 Mn |
| Mar 31, 2025 | 45.28 Mn |
| Dec 31, 2024 | 39.09 Mn |
| Sep 30, 2024 | 39.30 Mn |
| Jun 30, 2024 | 39.60 Mn |
| Mar 31, 2024 | 37.77 Mn |
| Dec 31, 2023 | 38.46 Mn |
| Sep 30, 2023 | 32.60 Mn |
| Jun 30, 2023 | 31.93 Mn |
| Mar 31, 2023 | 35.09 Mn |
| Dec 31, 2022 | 45.55 Mn |
| Sep 30, 2022 | 50.13 Mn |
| Jun 30, 2022 | 50.24 Mn |
| Mar 31, 2022 | 51.39 Mn |
| Dec 31, 2021 | 34.44 Mn |
| Sep 30, 2021 | 31.82 Mn |
API Access
Vanda Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();